BR0012591A - Agente profilático ou terapêutico para câncer - Google Patents

Agente profilático ou terapêutico para câncer

Info

Publication number
BR0012591A
BR0012591A BR0012591-1A BR0012591A BR0012591A BR 0012591 A BR0012591 A BR 0012591A BR 0012591 A BR0012591 A BR 0012591A BR 0012591 A BR0012591 A BR 0012591A
Authority
BR
Brazil
Prior art keywords
cancer
therapeutic agent
prophylactic
therapeutic
prophylatic
Prior art date
Application number
BR0012591-1A
Other languages
English (en)
Inventor
Shinichi Kurakata
Kosaku Fujiwara
Takashi Fujita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BR0012591A publication Critical patent/BR0012591A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Abstract

"AGENTE PROFILáTICO OU TERAPêUTICO PARA CâNCER". Compostos heterocíclicos fundidos de formulação farmacêutica (I): ou seus sais farmaceuticamente aceitáveis, úteis como agentes terapêuticos ou preventivos para o câncer, nos quais X é um grupo de anel de benzimidazol que pode possuir um a cinco substituintes selecionados dentre grupos alquila e assim por diante; Y é oxigênio ou enxofre; Z é tiazolidina-2,4-diona-5-il-metila ou semelhantes; R é hidrogênio ou semelhantes; e m é um número inteiro de 1 a 5.
BR0012591-1A 1999-07-19 2000-07-19 Agente profilático ou terapêutico para câncer BR0012591A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20447699 1999-07-19
PCT/JP2000/004858 WO2001005402A1 (fr) 1999-07-19 2000-07-19 Agents preventifs et therapeutiques du cancer

Publications (1)

Publication Number Publication Date
BR0012591A true BR0012591A (pt) 2002-04-09

Family

ID=16491170

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012591-1A BR0012591A (pt) 1999-07-19 2000-07-19 Agente profilático ou terapêutico para câncer

Country Status (18)

Country Link
US (1) US6569877B2 (pt)
EP (1) EP1197211A4 (pt)
KR (1) KR20020015383A (pt)
CN (1) CN1374864A (pt)
AU (1) AU760917B2 (pt)
BR (1) BR0012591A (pt)
CA (1) CA2379662A1 (pt)
CZ (1) CZ2002178A3 (pt)
HU (1) HUP0202340A3 (pt)
IL (1) IL147593A0 (pt)
MX (1) MXPA02000757A (pt)
NO (1) NO20020291L (pt)
NZ (1) NZ516636A (pt)
PL (1) PL352681A1 (pt)
RU (1) RU2219928C2 (pt)
TR (1) TR200200111T2 (pt)
WO (1) WO2001005402A1 (pt)
ZA (1) ZA200200316B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
US9092523B2 (en) 2005-02-28 2015-07-28 Search Engine Technologies, Llc Methods of and systems for searching by incorporating user-entered information
KR101532715B1 (ko) 2005-03-18 2015-07-02 써치 엔진 테크놀로지스, 엘엘씨 서치 결과를 향상시키기 위해 사용자로부터의 피드백을 적용하는 서치 엔진
WO2007100027A1 (ja) * 2006-03-02 2007-09-07 Daiichi Sankyo Company, Limited 光学活性なチアゾリジンジオン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3152992B2 (ja) * 1992-04-03 2001-04-03 株式会社興人 過酸化脂質の生成抑制及び消去用組成物
DK0805155T3 (da) * 1994-09-28 2002-07-08 Nippon Suisan Kaisha Ltd Hidtil ukendt tricyklisk, kondenseret heterocyklisk antioxidantforbindelse
JP3820601B2 (ja) * 1995-03-27 2006-09-13 大塚製薬株式会社 活性酸素消去剤
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5814647A (en) * 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
CZ302475B6 (cs) * 1997-10-08 2011-06-08 Sankyo Company Limited Substituované kumulované heterocyklické slouceniny
AU1507799A (en) * 1997-12-16 1999-07-05 Sankyo Company Limited Leukemia remedy
US6878896B2 (en) * 2002-07-24 2005-04-12 United Parcel Service Of America, Inc. Synchronous semi-automatic parallel sorting

Also Published As

Publication number Publication date
CZ2002178A3 (cs) 2002-05-15
IL147593A0 (en) 2002-08-14
NO20020291D0 (no) 2002-01-18
CN1374864A (zh) 2002-10-16
EP1197211A1 (en) 2002-04-17
US6569877B2 (en) 2003-05-27
AU760917B2 (en) 2003-05-22
RU2219928C2 (ru) 2003-12-27
PL352681A1 (en) 2003-09-08
MXPA02000757A (es) 2002-07-22
WO2001005402A1 (fr) 2001-01-25
NZ516636A (en) 2004-01-30
CA2379662A1 (en) 2001-01-25
HUP0202340A3 (en) 2006-03-28
US20020137776A1 (en) 2002-09-26
NO20020291L (no) 2002-03-18
TR200200111T2 (tr) 2002-08-21
ZA200200316B (en) 2003-06-25
HUP0202340A2 (hu) 2003-02-28
EP1197211A4 (en) 2004-09-01
AU6021200A (en) 2001-02-05
KR20020015383A (ko) 2002-02-27

Similar Documents

Publication Publication Date Title
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
BR0116063A (pt) Inibidores de sulfonamida heterocìclica da produção de beta amilóide e seus usos
BR0015605A (pt) Composição e uso
BR0014060A (pt) Derivado de quinolil propil piperidina, processo para preparação do mesmo, e, composição farmacêutica
BR9913903A (pt) Composto, método para tratar ou impedir um estado doentio, e, composição farmacêutica
ATE302775T1 (de) Carbolinderivate
BR0211305A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto
ATE416767T1 (de) 5-halo-tryptaminderivate als 5-ht6 und/oder 5-ht7 rezeptorliganden
PA8495101A1 (es) Derivados de 13-metileritromicina
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
ATE346067T1 (de) Carbolinderivate
BR0012901A (pt) Medicamentos de ß - carbolina
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
BR0110211A (pt) Derivados de oxadiazol tendo efeitos anticâncer
DE60112960D1 (de) Kondensierte pyridoindolderivate
ECSP066965A (es) Una composicion farmacéutica antibacterial
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
DK122191D0 (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
BR0012591A (pt) Agente profilático ou terapêutico para câncer
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
AR032601A1 (es) UN COMPUESTO DERIVADO DE QUINOLIN -4-IL, MEDICAMENTO QUE CONTIENE UNO O MAS DE DICHO COMPUESTO, PROCEDIMIENTO PARA LA PREPARACIoN DEL COMPUESTO Y EL USO DEL COMPUESTO
AR035006A1 (es) Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento.
DE60110124D1 (de) Kondensierte pyrazindionderivate als pde inhibitoren

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.